Yahoo Finance24d
Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
There were no clinically significant reductions in other immunoglobulins including IgG 3, IgA, IgE, or IgM compared to baseline. Based upon the rapid and deep reductions of total IgG observed with ...
Finanznachrichten24d
Biohaven Ltd.: Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
There were no clinically significant reductions in other immunoglobulins including IgG 3, IgA, IgE, or IgM compared to baseline. Based upon the rapid and deep reductions of total IgG observed with ...